Charlotte BarttelotinMMC writesMMC’s focus on Digital HealthI joined MMC in the late summer of 2021 to lead and build upon our already strong, track record in Digital Health. As a research-led VC…Jul 4, 2022Jul 4, 2022
Charlotte BarttelotWhy we invested in Sano GeneticsWe identified clinical trial technology as an attractive investment area based on our thesis surrounding the rise of decentralised trials…Mar 28, 2022Mar 28, 2022